N Bhardwaj1, A D Strickland, F Ahmad, A R Dennison, D M Lloyd. 1. Department of HPB surgery, Leicester Royal Infirmary, c/o Helen Southam, Mr DM Lloyd's Secretary Consultant HPB Surgeon, 6th Floor Balmoral Building, Leicester, UK. neilbhardwaj@yahoo.co.uk
Abstract
BACKGROUND: Ablation techniques for unresectable liver carcinomas have evolved immensely since their introduction. Results of studies involving these techniques are restricted to reports of patient case series, which are often not presented in a standardised manner. This review aims to summarise the major studies in ablation technologies and present them in a way that may make comparison between the major modalities easier. METHODS: All major databases (Medline, Cochrane, Embase and Pubmed) were searched for studies using microwave, radiofrequency or cryoablation to treat unresectable liver tumours. Only studies with at least 30 patients and 3-year follow-up were included. Complication, recurrence and survival rates of all studies are summarised and presented. RESULTS AND CONCLUSION: It is difficult to compare ablation modalities, as probe design and energy sources have evolved rapidly over the last decade. Ablation offers an invaluable palliative option and in some cases it may offer rates of cure approaching that of surgical resection with lower morbidity and mortality. Perhaps the time has come, therefore, for prospective large-scale randomised control trials to take place comparing ablation modalities to each other and surgical resection.
BACKGROUND: Ablation techniques for unresectable liver carcinomas have evolved immensely since their introduction. Results of studies involving these techniques are restricted to reports of patient case series, which are often not presented in a standardised manner. This review aims to summarise the major studies in ablation technologies and present them in a way that may make comparison between the major modalities easier. METHODS: All major databases (Medline, Cochrane, Embase and Pubmed) were searched for studies using microwave, radiofrequency or cryoablation to treat unresectable liver tumours. Only studies with at least 30 patients and 3-year follow-up were included. Complication, recurrence and survival rates of all studies are summarised and presented. RESULTS AND CONCLUSION: It is difficult to compare ablation modalities, as probe design and energy sources have evolved rapidly over the last decade. Ablation offers an invaluable palliative option and in some cases it may offer rates of cure approaching that of surgical resection with lower morbidity and mortality. Perhaps the time has come, therefore, for prospective large-scale randomised control trials to take place comparing ablation modalities to each other and surgical resection.
Authors: Chandrajit P Raut; Francesco Izzo; Paolo Marra; Lee M Ellis; Jean-Nicolas Vauthey; Francesco Cremona; Paolo Vallone; Angelo Mastro; Bruno D Fornage; Steven A Curley Journal: Ann Surg Oncol Date: 2005-06-20 Impact factor: 5.344
Authors: Rui Niu; Tristan D Yan; Jacqui C Zhu; Deborah Black; Francis Chu; David L Morris Journal: Ann Surg Oncol Date: 2007-05-02 Impact factor: 5.344
Authors: Tatjana Gruber-Rouh; Christian Marko; Axel Thalhammer; Nour-Eldin Nour-Eldin; Marcel Langenbach; Martin Beeres; Nagy N Naguib; Stephan Zangos; Thomas J Vogl Journal: Br J Radiol Date: 2016-05-26 Impact factor: 3.039
Authors: David M Lloyd; Kwan N Lau; Fenella Welsh; Kit-Fai Lee; David J Sherlock; Michael A Choti; John B Martinie; David A Iannitti Journal: HPB (Oxford) Date: 2011-06-24 Impact factor: 3.647
Authors: Marieke W J L A E Wertenbroek; Marianne Schepers; Hannetta J Kamminga-Rasker; Jan T Bottema; Anneke C Muller Kobold; Han Roelofsen; Koert P de Jong Journal: BMC Cancer Date: 2013-05-30 Impact factor: 4.430
Authors: D Miklavčič; G Serša; E Brecelj; J Gehl; D Soden; G Bianchi; P Ruggieri; C R Rossi; L G Campana; T Jarm Journal: Med Biol Eng Comput Date: 2012-11-21 Impact factor: 2.602